pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,993 catalysts · 18,987 approval · 5,159 phase readout · 5,000 device 510k · 4,728 grant · 2,487 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 31 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: filing×type: approval×clear all
type
  • approval18,987
  • phase readout5,159
  • device 510k5,000
  • grant4,728
  • 8k filing2,487
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • pdufa319
  • therapy area
    • Ophthalmology5

    Week of Apr 14, 2003

    4
    ›Apr 15, 2003approval8507d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 15, 2003approval8507d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 18, 2003approval8504d agoGLEEVEC (IMATINIB MESYLATE) — FDA approvalImatinib Mesylate Shilpa

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →Imatinib Mesylate Shilpa →fda approvals ↗
    ›Apr 20, 2003approval8502d agoDEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗

    Week of Apr 21, 2003

    5
    ›Apr 22, 2003approval8500d agoREGLAN (METOCLOPRAMIDE HYDROCHLORIDE) — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 22, 2003approval

    Week of Apr 28, 2003

    4
    ›Apr 28, 2003approval8494d agoMARINOL (DRONABINOL) — FDA approvalVertanical GmbH

    Sponsor: ALKEM LABS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 30, 2003approval

    Week of May 5, 2003

    3
    ›May 8, 2003approval8484d agoBUTORPHANOL TARTRATE PRESERVATIVE FREE (BUTORPHANOL TARTRATE) — FDA approvalBUTORPHANOL TARTRATE

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →BUTORPHANOL TARTRATE →fda approvals ↗
    ›May 9, 2003approval

    Week of May 12, 2003

    2
    ›May 15, 2003approval8477d agoIOPIDINE (APRACLONIDINE HYDROCHLORIDE) — FDA approvalHARROW, INC.

    Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›May 15, 2003approval

    Week of May 19, 2003

    3
    ›May 20, 2003approval8472d agoGLEEVEC (IMATINIB MESYLATE) — FDA approvalImatinib Mesylate Shilpa

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →Imatinib Mesylate Shilpa →fda approvals ↗
    ›May 21, 2003approval

    Week of May 26, 2003

    6
    ›May 27, 2003approval8465d agoMETADATE CD (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE CD

    Sponsor: AYTU BIOPHARMA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →METADATE CD →fda approvals ↗
    ›May 28, 2003approval

    Week of Jun 2, 2003

    6
    ›Jun 2, 2003approval8459d agoVENOFER (IRON SUCROSE) — FDA approvalInternational Medication Systems Ltd

    Sponsor: AM REGENT. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jun 3, 2003approval

    Week of Jun 9, 2003

    4
    ›Jun 11, 2003approval8450d agoSTALEVO 75 (CARBIDOPA) — FDA approvalcarbidopa

    Sponsor: ORION PHARMA. Form: TABLET. Route: ORAL

    full page →carbidopa →fda approvals ↗
    ›Jun 11, 2003approval

    Week of Jun 16, 2003

    4
    ›Jun 16, 2003approval8445d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

    Sponsor: SUN PHARM INDS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jun 19, 2003approval

    Week of Jun 23, 2003

    5
    ›Jun 26, 2003approval8435d agoVALPROATE SODIUM — FDA approvalVALPROATE SODIUM

    Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

    full page →VALPROATE SODIUM →fda approvals ↗
    ›Jun 26, 2003approval

    Week of Jun 30, 2003

    3
    ›Jun 30, 2003approval8431d agoROBINUL (GLYCOPYRROLATE) — FDA approvalGLYCOPYRROLATE

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →GLYCOPYRROLATE →fda approvals ↗
    ›Jun 30, 2003approval

    Week of Jul 7, 2003

    1
    ›Jul 8, 2003approval8423d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ← prev
    page 81 of 380
    next →
    8500d ago
    REGLAN (METOCLOPRAMIDE HYDROCHLORIDE) — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 22, 2003approval8500d agoREGLAN (METOCLOPRAMIDE HYDROCHLORIDE) — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 24, 2003approval8498d agoMETHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETHYLIN ER

    Sponsor: SPECGX LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METHYLIN ER →fda approvals ↗
    ›Apr 25, 2003approval8497d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    8492d ago
    DOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 30, 2003approval8492d agoNUBAIN (NALBUPHINE HYDROCHLORIDE) — FDA approvalTrevi Therapeutics, Inc.

    Sponsor: PH HEALTH. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →fda approvals ↗
    ›May 1, 2003approval8491d agoIDARUBICIN HYDROCHLORIDE — FDA approvalIDARUBICIN HYDROCHLORIDE

    Sponsor: PFIZER. Form: SOLUTION. Route: INTRAVENOUS

    full page →IDARUBICIN HYDROCHLORIDE →fda approvals ↗
    8483d ago
    MALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalatovaquone

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →atovaquone →fda approvals ↗
    ›May 9, 2003approval8483d agoIOPIDINE (APRACLONIDINE HYDROCHLORIDE) — FDA approvalHARROW, INC.

    Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    8477d ago
    DEMEROL (MEPERIDINE HYDROCHLORIDE) — FDA approvalMEPERIDINE HYDROCHLORIDE

    Sponsor: QUAGEN. Form: TABLET. Route: ORAL

    full page →MEPERIDINE HYDROCHLORIDE →fda approvals ↗
    8471d ago
    DOXYCYCLINE — FDA approvaldoxycycline ER

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →doxycycline ER →fda approvals ↗
    ›May 23, 2003approval8469d agoDEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →medroxyprogesterone acetate →fda approvals ↗
    8464d ago
    BREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approvalESMOLOL HYDROCHLORIDE

    Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →ESMOLOL HYDROCHLORIDE →fda approvals ↗
    ›May 30, 2003approval8462d agoADRENACLICK (EPINEPHRINE) — FDA approvalViatris Inc

    Sponsor: IMPAX. Form: INJECTABLE. Route: INTRAMUSCULAR, SUBCUTANEOUS

    full page →fda approvals ↗
    ›May 30, 2003approval8462d agoCLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: GEL. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    ›May 30, 2003approval8462d agoCLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: SWAB. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    ›May 30, 2003approval8462d agoCLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: LOTION. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    8458d ago
    TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jun 3, 2003approval8458d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jun 5, 2003approval8456d agoENBREL (ETANERCEPT) — FDA approvalAMGEN INC

    Sponsor: IMMUNEX. Form: SYRINGE

    full page →fda approvals ↗
    ›Jun 6, 2003approval8455d agoPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE (CODEINE PHOSPHATE) — FDA approvalPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE

    Sponsor: ACTAVIS MID ATLANTIC. Form: SYRUP. Route: ORAL

    full page →PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE →fda approvals ↗
    ›Jun 6, 2003approval8455d agoPROMETH VC W/ CODEINE (CODEINE PHOSPHATE) — FDA approvalCosette Pharmaceuticals Inc

    Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    8450d ago
    PRIMAQUINE (PRIMAQUINE PHOSPHATE) — FDA approvalprimaquine phosphate

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →primaquine phosphate →fda approvals ↗
    ›Jun 12, 2003approval8449d agoTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jun 12, 2003approval8449d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    8442d ago
    METADATE CD (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE CD

    Sponsor: AYTU BIOPHARMA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →METADATE CD →fda approvals ↗
    ›Jun 20, 2003approval8441d agoLAMICTAL (LAMOTRIGINE) — FDA approvalLAMOTRIGINE

    Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jun 20, 2003approval8441d agoLAMICTAL CD (LAMOTRIGINE) — FDA approvalLAMOTRIGINE

    Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    8435d ago
    PROSCAR (FINASTERIDE) — FDA approvalPROSCAR

    Sponsor: ORGANON. Form: TABLET. Route: ORAL

    full page →PROSCAR →fda approvals ↗
    ›Jun 26, 2003approval8435d agoDURAMORPH PF (MORPHINE SULFATE) — FDA approvalKapanol

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →Kapanol →fda approvals ↗
    ›Jun 27, 2003approval8434d agoLACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalCALCIUM CHLORIDE 10%

    Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →CALCIUM CHLORIDE 10% →fda approvals ↗
    ›Jun 27, 2003approval8434d agoKINERET (ANAKINRA) — FDA approvalSobi Inc

    Sponsor: BIOVITRUM AB. Form: VIAL. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    8431d ago
    ROBINUL (GLYCOPYRROLATE) — FDA approvalGLYCOPYRROLATE

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →GLYCOPYRROLATE →fda approvals ↗
    ›Jun 30, 2003approval8431d agoIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    $ANIP81.04+3.41%
    $NVS159.85+2.40%
    $AYTU2.2300-0.89%
    $HROW39.02-0.75%
    $NVS159.85+2.40%
    $ABBV263.20+2.45%
    $PFE25.25+2.35%
    $HROW39.02-0.75%
    $PFE25.25+2.35%
    $VTRS17.86+1.28%
    $PFE25.25+2.35%
    $PFE25.25+2.35%
    $PFE25.25+2.35%
    $AMGN393.10+4.48%
    $OGN13.52-0.15%
    $AYTU2.2300-0.89%
    $ORN12.42-2.13%
    $ANIP81.04+3.41%
    $ANIP81.04+3.41%
    $TRVI